Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coverage for ultrasound diagnostic

This article was originally published in The Gray Sheet

Executive Summary

CMS 1proposes Feb. 26 to remove national non-coverage of cardiac output Doppler monitoring, noting "there is sufficient evidence to conclude that esophageal Doppler monitoring of cardiac output for ventilated patients in the ICU and operative patients with a need for intra-operative fluid optimization is reasonable and necessary." CMS was asked to reconsider its existing non-coverage policy by UK-based Deltex Medical Group, whose CardioQ esophageal Doppler monitor was cleared by FDA in 2003 (2"The Gray Sheet" Sept. 11, 2006, p. 12). Comments on the proposal are due March 28, with a final decision expected in May...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT024541

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel